Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Repisalud
Publicación Artículo de revisión (ReviewArticle)

Current exposure to phthalates and DINCH in European children and adolescents - Results from the HBM4EU Aligned Studies 2014 to 2021

  • Vogel, Nina
  • Schmidt, Phillipp
  • Lange, Rosa
  • Gerofke, Antje
  • Sakhi, Amrit K
  • Haug, Line S
  • Jensen, Tina Kold
  • Frederiksen, Hanne
  • Szigeti, Tamás
  • Csákó, Zsófia
  • Palkovicova Murinova, Lubica
  • Šidlovská, Miroslava
  • Janasik, Beata
  • Wasowicz, Wojciech
  • Tratnik, Janja Snoj
  • Mazej, Darja
  • Gabriel, Catherine
  • Karakitsios, Spyros
  • Barbone, Fabio
  • Rosolen, Valentina
  • Rambaud, Loïc
  • Riou, Margaux
  • Murawski, Aline
  • Leseman, Daan
  • Koppen, Gudrun
  • Covaci, Adrian
  • Lignell, Sanna
  • Lindroos, Anna Karin
  • Zvonař, Martin
  • Andryskova, Lenka
  • Fábelová, Lucia
  • Richterová, Denisa
  • Horvat, Milena
  • Kosjek, Tina
  • Sarigiannis, Denis
  • Maroulis, Marios
  • Pedraza-Diaz, Susana
  • Cañas Portilla, Ana Isabel
  • Verheyen, Veerle J
  • Bastiaensen, Michiel
  • Gilles, Liese
  • Schoeters, Greet
  • Esteban-Lopez, Marta
  • Castaño, Argelia
  • Govarts, Eva
  • Koch, Holger M
  • Kolossa-Gehring, Marike
Phthalates are mainly used as plasticizers for polyvinyl chloride (PVC). Exposure to several phthalates is associated with different adverse effects most prominently on the development of reproductive functions. The HBM4EU Aligned Studies (2014-2021) have investigated current European exposure to ten phthalates (DEP, BBzP, DiBP, DnBP, DCHP, DnPeP, DEHP, DiNP, DiDP, DnOP) and the substitute DINCH to answer the open policy relevant questions which were defined by HBM4EU partner countries and EU institutions as the starting point of the programme. The exposure dataset includes ∼5,600 children (6-11 years) and adolescents (12-18 years) from up to 12 countries per age group and covering the North, East, South and West European regions. Study data from participating studies were harmonised with respect to sample size and selection of participants, selection of biomarkers, and quality and comparability of analytical results to provide a comparable perspective of European exposure. Phthalate and DINCH exposure were deduced from urinary excretions of metabolites, where concentrations were expressed as their key descriptor geometric mean (GM) and 95th percentile (P95). This study aims at reporting current exposure levels and differences in these between European studies and regions, as well as comparisons to human biomonitoring guidance values (HBM-GVs). GMs for children were highest for ∑DEHP metabolites (33.6 μg/L), MiBP (26.6 μg/L), and MEP (24.4 μg/L) and lowest for∑DiDP metabolites (1.91 μg/L) and ∑DINCH metabolites (3.57 μg/L). In adolescents highest GMs were found for MEP (43.3 μg/L), ∑DEHP metabolites (28.8 μg/L), and MiBP (25.6 μg/L) and lowest for ∑DiDP metabolites (= 2.02 μg/L) and ∑DINCH metabolites (2.51 μg/L). In addition, GMs and P95 stratified by European region, sex, household education level, and degree of urbanization are presented. Differences in average biomarker concentrations between sampling sites (data collections) ranged from factor 2 to 9. Compared to the European average, children in the sampling sites OCC (Denmark), InAirQ (Hungary), and SPECIMEn (The Netherlands) had the lowest concentrations across all metabolites and ESTEBAN (France), NAC II (Italy), and CROME (Greece) the highest. For adolescents, comparably higher metabolite concentrations were found in NEB II (Norway), PCB cohort (Slovakia), and ESTEBAN (France), and lower concentrations in POLAES (Poland), FLEHS IV (Belgium), and GerES V-sub (Germany). Multivariate analyses (Survey Generalized Linear Models) indicate compound-specific differences in average metabolite concentrations between the four European regions. Comparison of individual levels with HBM-GVs revealed highest rates of exceedances for DnBP and DiBP, with up to 3 and 5%, respectively, in children and adolescents. No exceedances were observed for DEP and DINCH. With our results we provide current, detailed, and comparable data on exposure to phthalates in children and - for the first time - in adolescents, and - for the first time - on DINCH in children and adolescents of all four regions of Europe which are particularly suited to inform exposure and risk assessment and answer open policy relevant questions.
Repisalud
Publicación Artículo de revisión (ReviewArticle)

Exposure to flame retardants in European children - Results from the HBM4EU aligned studies

  • van der Schyff, Veronica
  • Kalina, Jiři
  • Govarts, Eva
  • Gilles, Liese
  • Schoeters, Greet
  • Castaño, Argelia
  • Esteban-Lopez, Marta
  • Kohoutek, Jiří
  • Kukučka, Petr
  • Covaci, Adrian
  • Koppen, Gudrun
  • Andrýsková, Lenka
  • Piler, Pavel
  • Klánová, Jana
  • Jensen, Tina Kold
  • Rambaud, Loïc
  • Riou, Margaux
  • Lamoree, Marja
  • Kolossa-Gehring, Marike
  • Vogel, Nina
  • Weber, Till
  • Göen, Thomas
  • Gabriel, Catherine
  • Sarigiannis, Dimosthenis A
  • Sakhi, Amrit Kaur
  • Haug, Line Småstuen
  • Palkovicova Murinova, Lubica
  • Fábelová, Lucia
  • Tratnik, Janja Snoj
  • Mazej, Darja
  • Melymuk, Lisa
Many legacy and emerging flame retardants (FRs) have adverse human and environmental health effects. This study reports legacy and emerging FRs in children from nine European countries from the HBM4EU aligned studies. Studies from Belgium, Czech Republic, Germany, Denmark, France, Greece, Slovenia, Slovakia, and Norway conducted between 2014 and 2021 provided data on FRs in blood and urine from 2136 children. All samples were collected and analyzed in alignment with the HBM4EU protocols. Ten halogenated FRs were quantified in blood, and four organophosphate flame retardants (OPFR) metabolites quantified in urine. Hexabromocyclododecane (HBCDD) and decabromodiphenyl ethane (DBDPE) were infrequently detected (<16% of samples). BDE-47 was quantified in blood from Greece, France, and Norway, with France (0.36 ng/g lipid) having the highest concentrations. BDE-153 and -209 were detected in <40% of samples. Dechlorane Plus (DP) was quantified in blood from four countries, with notably high median concentrations of 16 ng/g lipid in Slovenian children. OPFR metabolites had a higher detection frequency than other halogenated FRs. Diphenyl phosphate (DPHP) was quantified in 99% of samples across 8 countries at levels ∼5 times higher than other OPFR metabolites (highest median in Slovenia of 2.43 ng/g lipid). FR concentrations were associated with lifestyle factors such as cleaning frequency, employment status of the father of the household, and renovation status of the house, among others. The concentrations of BDE-47 in children from this study were similar to or lower than FRs found in adult matrices in previous studies, suggesting lower recent exposure and effectiveness of PBDE restrictions.
Repisalud
Publicación Artículo de revisión (ReviewArticle)

A critical review to identify data gaps and improve risk assessment of bisphenol A alternatives for human health

  • Mhaouty-Kodja, Sakina
  • Zalko, Daniel
  • Tait, Sabrina
  • Testai, Emanuela
  • Viguié, Catherine
  • Corsini, Emanuela
  • Grova, Nathalie
  • Buratti, Franca Maria
  • Cabaton, Nicolas J
  • Coppola, Lucia
  • De la Vieja, Antonio
  • Dusinska, Maria
  • El Yamani, Naouale
  • Galbiati, Valentina
  • Iglesias-Hernandez, Patricia
  • Kohl, Yvonne
  • Maddalon, Ambra
  • Marcon, Francesca
  • Naulé, Lydie
  • Rundén-Pran, Elise
  • Salani, Francesca
  • Santori, Nicoletta
  • Torres-Ruiz, Mónica
  • Turner, Jonathan D
  • Adamovsky, Ondrej
  • Aiello-Holden, Kiara
  • Dirven, Hubert
  • Louro, Henriqueta
  • Silva, Maria João
Bisphenol A (BPA), a synthetic chemical widely used in the production of polycarbonate plastic and epoxy resins, has been associated with a variety of adverse effects in humans including metabolic, immunological, reproductive, and neurodevelopmental effects, raising concern about its health impact. In the EU, it has been classified as toxic to reproduction and as an endocrine disruptor and was thus included in the candidate list of substances of very high concern (SVHC). On this basis, its use has been banned or restricted in some products. As a consequence, industries turned to bisphenol alternatives, such as bisphenol S (BPS) and bisphenol F (BPF), which are now found in various consumer products, as well as in human matrices at a global scale. However, due to their toxicity, these two bisphenols are in the process of being regulated. Other BPA alternatives, whose potential toxicity remains largely unknown due to a knowledge gap, have also started to be used in manufacturing processes. The gradual restriction of the use of BPA underscores the importance of understanding the potential risks associated with its alternatives to avoid regrettable substitutions. This review aims to summarize the current knowledge on the potential hazards related to BPA alternatives prioritized by European Regulatory Agencies based on their regulatory relevance and selected to be studied under the European Partnership for the Assessment of Risks from Chemicals (PARC): BPE, BPAP, BPP, BPZ, BPS-MAE, and TCBPA. The focus is on data related to toxicokinetic, endocrine disruption, immunotoxicity, developmental neurotoxicity, and genotoxicity/carcinogenicity, which were considered the most relevant endpoints to assess the hazard related to those substances. The goal here is to identify the data gaps in BPA alternatives toxicology and hence formulate the future directions that will be taken in the frame of the PARC project, which seeks also to enhance chemical risk assessment methodologies using new approach methodologies (NAMs).